David F. Hale
Chief Executive Officer, MICROMET, INC.
Companies
- Dermata Therapeutics, Inc.Board member Aug 12, 2021 to now1
- Oncternal Therapeutics, Inc.Board member Jun 11, 2019 to Jun 24, 20242
- BIOCEPT INCBoard member Jan 4, 2016 to Dec 10, 20213
- Histogen Inc.Board member Jul 24, 2013 to Jul 1, 20194
- BIOCEPT INCChair Feb 4, 2014 to Nov 10, 20155
Holdings
Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.
Shares held
- Dermata Therapeutics, Inc. DRMA462 shares6$404 at $0.87Jan 23, 2025
- BIOCEPT INC897 shares7Dec 9, 2021
- Oncternal Therapeutics, Inc.1,631 shares8Feb 27, 2024
As of each latest filing. The line shows shares held over time.
Recent filings
- Jan 23, 2025Granted 78,741 shares of Dermata Therapeutics, Inc.6
- Feb 23, 2024Bought 266 shares at $9.04 of Oncternal Therapeutics, Inc.8
- Feb 23, 2024Bought 714 shares at $9.04 of Oncternal Therapeutics, Inc.8
- Oct 6, 2022Granted 30,155 shares of Dermata Therapeutics, Inc.9
- Jul 7, 2022Granted 26,441 shares of Dermata Therapeutics, Inc.10
- Apr 7, 2022Granted 15,466 shares of Dermata Therapeutics, Inc.11
- Dec 9, 2021Sold 71 shares at $4.07 of BIOCEPT INC7
- Dec 9, 2021Sold 11 shares at $4.07 of BIOCEPT INC7
- Dec 9, 2021Sold 363 shares at $4.06 of BIOCEPT INC7
- Oct 1, 2021Gift 125,000 shares of Oncternal Therapeutics, Inc.12
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1
- 2
- 3SEC EDGARBIOCEPT INC, Board member
- 4SEC EDGARHistogen Inc., Board member
- 5SEC EDGARBIOCEPT INC, Chair
- 6
- 7
- 8
- 9SEC EDGARForm 4 filed Oct 7, 2022
- 10SEC EDGARForm 4 filed Jul 8, 2022
- 11SEC EDGARForm 4 filed Apr 8, 2022
- 12SEC EDGARForm 5 filed Feb 11, 2022